Budesonide (Budenofalk 3 mg) and Darunavir: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Strong CYP3A inhibition increases corticosteroid exposure.
Clinical significance and safety
For ritonavir-boosted darunavir (PREZISTA/ritonavir), this corticosteroid, including applicable inhaled products, can produce adrenal suppression or Cushing-like effects. Exact route and duration need clinical review; do not abruptly change steroid treatment yourself.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.